BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 7738190)

  • 1. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.
    Purcell-Huynh DA; Farese RV; Johnson DF; Flynn LM; Pierotti V; Newland DL; Linton MF; Sanan DA; Young SG
    J Clin Invest; 1995 May; 95(5):2246-57. PubMed ID: 7738190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
    Véniant MM; Pierotti V; Newland D; Cham CM; Sanan DA; Walzem RL; Young SG
    J Clin Invest; 1997 Jul; 100(1):180-8. PubMed ID: 9202070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
    Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).
    Callow MJ; Verstuyft J; Tangirala R; Palinski W; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1639-46. PubMed ID: 7657833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV.
    Cohen RD; Castellani LW; Qiao JH; Van Lenten BJ; Lusis AJ; Reue K
    J Clin Invest; 1997 Apr; 99(8):1906-16. PubMed ID: 9109435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E.
    Espinosa-Heidmann DG; Sall J; Hernandez EP; Cousins SW
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):260-6. PubMed ID: 14691182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice.
    Mancini FP; Newland DL; Mooser V; Murata J; Marcovina S; Young SG; Hammer RE; Sanan DA; Hobbs HH
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1911-6. PubMed ID: 7583571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142).
    Fazio S; Sanan DA; Lee YL; Ji ZS; Mahley RW; Rall SC
    Arterioscler Thromb; 1994 Nov; 14(11):1873-9. PubMed ID: 7947615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet.
    Powell-Braxton L; Véniant M; Latvala RD; Hirano KI; Won WB; Ross J; Dybdal N; Zlot CH; Young SG; Davidson NO
    Nat Med; 1998 Aug; 4(8):934-8. PubMed ID: 9701246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerotic lesions in response to a cholesterol-rich diet.
    Fan J; Shimoyamada H; Sun H; Marcovina S; Honda K; Watanabe T
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):88-94. PubMed ID: 11145938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
    Farese RV; Véniant MM; Cham CM; Flynn LM; Pierotti V; Loring JF; Traber M; Ruland S; Stokowski RS; Huszar D; Young SG
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6393-8. PubMed ID: 8692825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
    Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
    J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice.
    Voyiaziakis E; Goldberg IJ; Plump AS; Rubin EM; Breslow JL; Huang LS
    J Lipid Res; 1998 Feb; 39(2):313-21. PubMed ID: 9507992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).
    Linton MF; Farese RV; Chiesa G; Grass DS; Chin P; Hammer RE; Hobbs HH; Young SG
    J Clin Invest; 1993 Dec; 92(6):3029-37. PubMed ID: 8254057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of induced atherosclerosis in h-apo AI transgenic mice by overexpression of human apo AI in the aortic wall.
    Li H; Gu S; Cao X; Wang Z; She M
    Chin Med J (Engl); 2000 Jul; 113(7):657-61. PubMed ID: 11776042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of plasma and hepatic variables with rates of plasma low-density lipoprotein apolipoprotein B metabolism in baboons fed low- and high-fat diets.
    Kushwaha RS; Barrett PH; Reardon CA; Lewis DS; Carey KD; Getz GS; McGill HC
    Metabolism; 1995 Aug; 44(8):1058-66. PubMed ID: 7637648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ; van den Maagdenberg AM; Gijbels MJ; van der Boom H; HogenEsch H; Frants RR; Hofker MH; Havekes LM
    J Clin Invest; 1994 Apr; 93(4):1403-10. PubMed ID: 8163645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary cholate is required for antiatherogenic effects of ethanol in mouse models.
    Deeg MA
    Alcohol Clin Exp Res; 2003 Sep; 27(9):1499-506. PubMed ID: 14506412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Bourassa PA; Milos PM; Gaynor BJ; Breslow JL; Aiello RJ
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10022-7. PubMed ID: 8816744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.